Skip to main content
Fig. 2 | Cancers of the Head & Neck

Fig. 2

From: Genomic insights into head and neck cancer

Fig. 2

Potential therapeutic intervention based on genomic alterations. Therapeutics targeting of a cell cycle and b RTK/RAS/PI(3)K signaling associated elements. Percentages are based on the The Cancer Genome Atlas Network report [19]. RTK = receptor tyrosine kinase

Back to article page

Cancers of the Head & Neck

ISSN: 2059-7347

Contact us